Denosumab (Prolia) Prefilled Syringe from Japan
Denosumab is a human monoclonal antibody inhibiting RANKL for osteoporosis. HTS 3002.15.00.11 applies to this immunological product in retail syringes.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Specify RANKL mechanism; avoid general hormone misclassification